Literature DB >> 19591432

Compositional analysis of heparin/heparan sulfate interacting with fibroblast growth factor.fibroblast growth factor receptor complexes.

Fuming Zhang1, Zhenqing Zhang, Xinfu Lin, Andrew Beenken, Anna V Eliseenkova, Moosa Mohammadi, Robert J Linhardt.   

Abstract

Heparan sulfate (HS) proteoglycans (PGs) interact with a number of extracellular signaling proteins, thereby playing an essential role in the regulation of many physiological processes. One major function of HS is to interact with fibroblast growth factors (FGFs) and their receptors (FGFRs) and form FGF.HS.FGFR signaling complexes. Past studies primarily examined the selectivity of HS for FGF or FGFR. In this report, we used a new strategy to study the structural specificity of HS binding to 10 different FGF.FGFR complexes. Oligosaccharide libraries prepared from heparin, 6-desulfated heparin, and HS were used for the interaction studies by solution competition surface plasmon resonance (SPR) and filter trapping assays. Specific oligosaccharides binding to FGF.FGFR complexes were subjected to polyacrylamide gel electrophoresis (PAGE) analysis and disaccharide compositional analysis using liquid chromatography and mass spectrometry. The competition SPR studies using sized oligosaccharide mixtures showed that binding of each of the tested FGFs or FGF.FGFR complexes to heparin immobilized to an SPR chip was size-dependent. The 6-desulfated heparin oligosaccharides exhibited a reduced level of inhibition of FGF and FGF.FGFR complex binding to heparin in the competition experiments. Heparin and the 6-desulfated heparin exhibited higher levels of inhibition of the FGF.FGFR complex binding to heparin than of FGF binding to heparin. In the filter trapping experiments, PAGE analysis showed different affinities between the FGF.FGFR complexes and oligosaccharides. Disaccharide analysis showed that HS disaccharides with a degree of polymerization of 10 (dp10) had high binding selectivity, while dp10 heparin and dp10 6-desulfated heparin showed reduced or no selectivity for the different FGF.FGFR complexes tested.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19591432      PMCID: PMC3348549          DOI: 10.1021/bi9006379

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

Review 1.  Functions of cell surface heparan sulfate proteoglycans.

Authors:  M Bernfield; M Götte; P W Park; O Reizes; M L Fitzgerald; J Lincecum; M Zako
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

2.  Preparation of completely 6-O-desulfated heparin and its ability to enhance activity of basic fibroblast growth factor.

Authors:  Y Kariya; M Kyogashima; K Suzuki; T Isomura; T Sakamoto; K Horie; M Ishihara; R Takano; K Kamei; S Hara
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

3.  Crystal structures of two FGF-FGFR complexes reveal the determinants of ligand-receptor specificity.

Authors:  A N Plotnikov; S R Hubbard; J Schlessinger; M Mohammadi
Journal:  Cell       Date:  2000-05-12       Impact factor: 41.582

4.  Drosophila heparan sulfate 6-O-sulfotransferase (dHS6ST) gene. Structure, expression, and function in the formation of the tracheal system.

Authors:  K Kamimura; M Fujise; F Villa; S Izumi; H Habuchi; K Kimata; H Nakato
Journal:  J Biol Chem       Date:  2001-03-08       Impact factor: 5.157

Review 5.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development.

Authors:  D M Ornitz
Journal:  Bioessays       Date:  2000-02       Impact factor: 4.345

6.  Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2.

Authors:  J Kreuger; M Salmivirta; L Sturiale; G Giménez-Gallego; U Lindahl
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

7.  Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome.

Authors:  O A Ibrahimi; A V Eliseenkova; A N Plotnikov; K Yu; D M Ornitz; M Mohammadi
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-05       Impact factor: 11.205

8.  Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis.

Authors:  L Lundin; H Larsson; J Kreuger; S Kanda; U Lindahl; M Salmivirta; L Claesson-Welsh
Journal:  J Biol Chem       Date:  2000-08-11       Impact factor: 5.157

9.  Crystal structure of fibroblast growth factor 9 reveals regions implicated in dimerization and autoinhibition.

Authors:  A N Plotnikov; A V Eliseenkova; O A Ibrahimi; Z Shriver; R Sasisekharan; M A Lemmon; M Mohammadi
Journal:  J Biol Chem       Date:  2000-11-01       Impact factor: 5.157

10.  Minimum FGF2 binding structural requirements of heparin and heparan sulfate oligosaccharides as determined by NMR spectroscopy.

Authors:  Sara Guglier; Milos Hricovíni; Rahul Raman; Laura Polito; Giangiacomo Torri; Benito Casu; Ram Sasisekharan; Marco Guerrini
Journal:  Biochemistry       Date:  2008-12-30       Impact factor: 3.162

View more
  35 in total

Review 1.  Specific sides to multifaceted glycosaminoglycans are observed in embryonic development.

Authors:  Kenneth L Kramer
Journal:  Semin Cell Dev Biol       Date:  2010-07-03       Impact factor: 7.727

2.  Characterization of the interaction between Robo1 and heparin and other glycosaminoglycans.

Authors:  Fuming Zhang; Heather A Moniz; Benjamin Walcott; Kelley W Moremen; Robert J Linhardt; Lianchun Wang
Journal:  Biochimie       Date:  2013-08-28       Impact factor: 4.079

3.  Characterization of interactions between heparin/glycosaminoglycan and adeno-associated virus.

Authors:  Fuming Zhang; Javier Aguilera; Julie M Beaudet; Qing Xie; Thomas F Lerch; Omar Davulcu; Wilfredo Colón; Michael S Chapman; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-08-28       Impact factor: 3.162

4.  FGF-FGFR signaling mediated through glycosaminoglycans in microtiter plate and cell-based microarray platforms.

Authors:  Eric Sterner; Luciana Meli; Seok-Joon Kwon; Jonathan S Dordick; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-12-06       Impact factor: 3.162

5.  Interaction of Zika Virus Envelope Protein with Glycosaminoglycans.

Authors:  So Young Kim; Jing Zhao; Xinyue Liu; Keith Fraser; Lei Lin; Xing Zhang; Fuming Zhang; Jonathan S Dordick; Robert J Linhardt
Journal:  Biochemistry       Date:  2017-02-13       Impact factor: 3.162

6.  Effect of heparin oligomer chain length on the activation of valvular interstitial cells.

Authors:  Sara Pedron; Andrea M Kasko; Carmen Peinado; Kristi S Anseth
Journal:  Biomacromolecules       Date:  2010-06-14       Impact factor: 6.988

7.  Interactions between Sclerostin and Glycosaminoglycans.

Authors:  Fuming Zhang; Jing Zhao; Xinyue Liu; Robert J Linhardt
Journal:  Glycoconj J       Date:  2019-12-11       Impact factor: 2.916

8.  Gas-Phase Analysis of the Complex of Fibroblast GrowthFactor 1 with Heparan Sulfate: A Traveling Wave Ion Mobility Spectrometry (TWIMS) and Molecular Modeling Study.

Authors:  Yuejie Zhao; Arunima Singh; Yongmei Xu; Chengli Zong; Fuming Zhang; Geert-Jan Boons; Jian Liu; Robert J Linhardt; Robert J Woods; I Jonathan Amster
Journal:  J Am Soc Mass Spectrom       Date:  2016-09-23       Impact factor: 3.109

9.  Synthetic heparan sulfate oligosaccharides inhibit endothelial cell functions essential for angiogenesis.

Authors:  Claire L Cole; Steen U Hansen; Marek Baráth; Graham Rushton; John M Gardiner; Egle Avizienyte; Gordon C Jayson
Journal:  PLoS One       Date:  2010-07-21       Impact factor: 3.240

10.  Structural studies of the interaction of Crataeva tapia bark protein with heparin and other glycosaminoglycans.

Authors:  Fuming Zhang; Benjamin Walcott; Dongwen Zhou; Alla Gustchina; Yi Lasanajak; David F Smith; Rodrigo S Ferreira; Maria Tereza S Correia; Patrícia M G Paiva; Nicolai V Bovin; Alexander Wlodawer; Maria L V Oliva; Robert J Linhardt
Journal:  Biochemistry       Date:  2013-03-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.